📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people (2023)

First Author: Whitaker M

Attributed to: Capital award for UK DRI at Imperial College London funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-40643-w

Publication URI: http://dx.doi.org/10.1038/s41467-023-40643-w

Type: Journal Article/Review

Parent Publication: Nature Communications

Issue: 1